MedWatch: The FDA Medical Products Reporting Program

Forms and Documents

Document	Type	Status	Availability

No forms / supporting documents in this ICR. Check IC Document Collections.

IC Document Collections

IC ID	Collection	Type	Status	Form
5857	MedWatch: The FDA Medical Products Reporting Program	Form	Migrated

ICR Details

OMB Control No: 0910-0291	ICR Reference No: 200306-0910-004
Status: Historical Active	Previous ICR Reference No: 200011-0910-004
Agency/Subagency: HHS/FDA	Agency Tracking No:
Title: MedWatch: The FDA Medical Products Reporting Program
Type of Information Collection: Extension without change of a currently approved collection	Common Form ICR:  No
Type of Review Request: Regular
OIRA Conclusion Action: Approved with change	Conclusion Date: 09/12/2003
	Date Received in OIRA: 06/25/2003
Terms of Clearance: As requested by the agency, in addition to the approval of the revised forms, the existing forms are approved for continued use for the next 6 months to allow for the industry to make necessary changes to their computerized systems. FDA shall continue to work with the regulated community to simplify reporting to the extent possible, and work closely with interested parties to incorporate public comment on any efforts to change the reporting requirements prior to OMB submission.

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	03/31/2005	03/31/2005	09/30/2003
Responses	372,987	0	332,414
Time Burden (Hours)	356,369	0	332,414
Cost Burden (Dollars)	0	0	0

---

Abstract: Reporting of adverse events and product problems by health professionals to the FDA either directly or via the manufacturer is critical to an effective national postmarketing surveillance system. The overall MedWatch program is a national educational/ promotional initiative designed both to educate all health professionals about the critical importance of being aware of, monitoring for, and reporting adverse events and problems to FDA and/or the manufacturer, and to ensure that new medical product safety information is communicated rapidly to the health professional community, thereby improving patient care....

---

Authorizing Statute(s): None

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:

---

Federal Register Notices & Comments

Did the Agency receive public comments on this ICR? No

---

Number of Information Collection (IC) in this ICR: 1

IC Title	Form No.	Form Name
MedWatch: The FDA Medical Products Reporting Program	FDA-3500, 3500A

---

ICR Summary of Burden

	Total Approved	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	372,987	332,414	0	0	40,573	0
Annual Time Burden (Hours)	356,369	332,414	0	0	23,955	0
Annual Cost Burden (Dollars)	0	0	0	0	0	0

Burden increases because of Program Change due to Agency Discretion: No

Burden Increase Due to:

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement:

---

Annual Cost to Federal Government: $0

Does this IC contain surveys, censuses, or employ statistical methods? No

Is the Supporting Statement intended to be a Privacy Impact Assessment required by the E-Government Act of 2002? No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? Uncollected

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? Uncollected

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? Uncollected

Is this ICR related to the Pandemic Response? Uncollected

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 06/25/2003

---